California — Alameda County (Most Active State Venue)
California applies the Kelly-Frye standard for expert admissibility, which asks whether the scientific methodology used by an expert is generally accepted in the relevant scientific community — not whether the judge agrees with the expert's conclusions. Given the 91-scientist consensus statement in Nature Reviews Endocrinology (2021) and the endorsement by HHS Secretary RFK Jr. (September 2025), plaintiffs' experts can argue with force that the prenatal-acetaminophen-to-neurodevelopmental-risk methodology has broad scientific acceptance. Alameda County in the San Francisco Bay Area has been the primary venue for coordinated California acetaminophen-autism cases. California also has strong minority tolling provisions — the statute of limitations for a child's claim does not run until the child turns 18, making California particularly favorable for families with younger children.
Illinois — St. Clair, Madison, and Cook Counties
Illinois applies the Frye standard for expert admissibility and has a strong mass tort bar with experience in plaintiff-favorable venues. St. Clair County (Metro East / St. Louis area), Madison County (also Metro East), and Cook County (Chicago) are all active venues for pharmaceutical mass tort litigation. Illinois courts have repeatedly permitted complex pharmaceutical causation expert testimony that might not survive a federal Daubert challenge. The October 2025 Texas AG suit and September 2025 HHS announcement strengthened the Frye general-acceptance argument in Illinois as well as California.
Texas — Proceed With Caution
Texas presents a complicating factor for private plaintiffs. While the Texas AG filed suit against J&J and Kenvue in October 2025, generating significant local news coverage, Texas has a pharmaceutical safe harbor law that limits private tort claims against drug manufacturers in certain circumstances. Families in Texas who saw the AG's lawsuit and assumed they could easily file a private claim may be disappointed. An attorney familiar with Texas pharmaceutical liability law should be consulted before filing. The Texas AG's suit is a government enforcement action, not a vehicle for private plaintiff recovery.
Frequently Asked Questions
Related Pages
Tylenol Liver Damage Lawsuit
Acetaminophen — the active ingredient in Tylenol — is the leading cause of acute liver failure in the United States, responsible for approximately 56,000 emergency room visits, 26,000 hospitalizations, and nearly 500 deaths each year. Lawsuits allege that McNeil Consumer Healthcare and parent company Johnson & Johnson failed to adequately warn consumers about the narrow margin between a therapeutic dose and a potentially fatal overdose. Even doses only slightly above the recommended amount, especially when combined with alcohol use or taken across multiple acetaminophen-containing products, can cause catastrophic liver damage. If you or a loved one suffered acute liver failure, liver transplant, or death linked to acetaminophen use, you may be eligible for compensation. These liver damage claims are separate from the Tylenol autism/ADHD litigation — they involve direct injury to the person who took the medication.
Learn moreLearn moreLearn moreLearn moreLearn moreLearn moreTylenol Autism Lawsuit Lawsuit
Acetaminophen — sold under the brand name Tylenol by Kenvue (formerly Johnson & Johnson) and as dozens of store-brand generics by Walmart, CVS, Walgreens, Target, Costco, Meijer, and others — was the most commonly used pain reliever during pregnancy in the United States for decades. Starting with a landmark 2018 American Journal of Epidemiology meta-analysis of 130,000 mother-child pairs, and culminating in a 2021 consensus statement signed by 91 scientists published in Nature Reviews Endocrinology, accumulating evidence linked prolonged prenatal acetaminophen exposure to significantly elevated risks of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). The federal multidistrict litigation, MDL-3043 (In re Acetaminophen — ASD/ADHD Products Liability Litigation) in the Southern District of New York, was dismissed in August 2024 after Judge Denise L. Cote excluded all plaintiffs' general causation experts under the Daubert standard. Critically, the Second Circuit Court of Appeals heard oral arguments on November 17, 2025 — and two of the three judges on the panel openly questioned whether Judge Cote acted too aggressively in excluding the expert testimony. A reversal by the Second Circuit could reinstate thousands of federal cases. Separately, California state courts (Alameda County) and Illinois state courts (St. Clair, Madison, and Cook counties) have active acetaminophen-autism cases proceeding under the Frye admissibility standard, which does not apply the same gatekeeping test that closed the federal MDL. Store-brand acetaminophen users have the same legal claims as Tylenol brand users — the failure-to-warn theory applies equally to Walmart's Equate brand, CVS Health brand, Walgreens brand, Costco Kirkland brand, and all other private-label acetaminophen products.
View full case overview